Wikidata

(Q64652605)

English

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory AML

clinical trial

In more languages

Statements

short name
VALOR (English)
0 references
title
A Phase 3, Randomized, Controlled, Double-Blind, Multinational Clinical Study of the Efficacy and Safety of Vosaroxin and Cytarabine Versus Placebo and Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (VALOR) (English)
0 references
country
Australia
0 references
Austria
0 references
Belgium
0 references
Canada
0 references
France
0 references
Germany
0 references
Hungary
0 references
Italy
0 references
New Zealand
0 references
Poland
0 references
Spain
0 references
United Kingdom
0 references
start time
17 December 2010
0 references
end time
26 September 2014
0 references
number of participants
711
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64652605&oldid=1857873433"